Cargando…

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells

Glioblastoma multiforme (GBM) continues to be the most frequently diagnosed and lethal primary brain tumor. Adjuvant chemo-radiotherapy remains the standard of care following surgical resection. In this study, using reverse phase protein arrays (RPPAs), we assessed the biological effects of radiatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maachani, Uday B., Shankavaram, Uma, Kramp, Tamalee, Tofilon, Philip J., Camphausen, Kevin, Tandle, Anita T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340228/ https://www.ncbi.nlm.nih.gov/pubmed/27764801 http://dx.doi.org/10.18632/oncotarget.12670

Ejemplares similares

Modulation of miR-21 signaling by MPS1 in human glioblastoma
por: Maachani, Uday B., et al.
Publicado: (2015)

Molecular profiling of MPS1 gene silencing in U251 glioma cell line
por: Shankavaram, Uma, et al.
Publicado: (2015)

Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose
por: Sproull, Mary, et al.
Publicado: (2013)

Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma
por: Shankavaram, Uma T, et al.
Publicado: (2012)

Detection of metabolic change in glioblastoma cells after radiotherapy using hyperpolarized (13)C‐MRI
por: Kawai, Tatsuya, et al.
Publicado: (2021)

Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA
por: Wahba, Amy, et al.
Publicado: (2017)

Radiosensitization by the novel DNA intercalating agent vosaroxin
por: Gordon, Ira K, et al.
Publicado: (2012)

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
por: Buchanan, Ian M, et al.
Publicado: (2011)

Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb
por: Degorre, Charlotte, et al.
Publicado: (2022)

Computational analysis of the mesenchymal signature landscape in gliomas
por: Celiku, Orieta, et al.
Publicado: (2017)

StRAP: An Integrated Resource for Profiling High-Throughput Cancer Genomic Data from Stress Response Studies
por: Johnson, Seth, et al.
Publicado: (2012)

Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP
por: Celiku, Orieta, et al.
Publicado: (2014)

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
por: Degorre, Charlotte, et al.
Publicado: (2021)

Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
por: Krauze, Andra V., et al.
Publicado: (2023)

LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1
por: Patel, Deven, et al.
Publicado: (2019)

Mitotic Protein Kinase 1: Role in Spindle Assembly Checkpoint Revisited
por: Tandle, Anita, et al.
Publicado: (2016)

High throughput evaluation of gamma-H2AX
por: Avondoglio, Dane, et al.
Publicado: (2009)

The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma
por: Ma, Qing, et al.
Publicado: (2017)

Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization
por: Rath, Barbara H, et al.
Publicado: (2015)

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker
por: Gouazé-Andersson, Valérie, et al.
Publicado: (2018)

Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells
por: Rath, Barbara H., et al.
Publicado: (2013)

Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
por: Das, Shaoli, et al.
Publicado: (2020)

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data
por: Das, Shaoli, et al.
Publicado: (2020)

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response
por: Das, Shaoli, et al.
Publicado: (2019)

Novel Murine Biomarkers of Radiation Exposure Using An Aptamer-Based Proteomic Technology
por: Sproull, Mary, et al.
Publicado: (2021)

SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment
por: Deng, Xiang, et al.
Publicado: (2019)

Acid ceramidase confers radioresistance to glioblastoma cells
por: Doan, Ninh B., et al.
Publicado: (2017)

Synthetic Lethal Drug Combinations Targeting Proteasome and Histone Deacetylase Inhibitors in TP53-Mutated Cancers
por: Das, Shaoli, et al.
Publicado: (2020)

Improving Radiation Response in Glioblastoma Using ECO/siRNA Nanoparticles Targeting DNA Damage Repair
por: Lee, Jennifer A., et al.
Publicado: (2020)

Preclinical models in radiation oncology
por: Kahn, Jenna, et al.
Publicado: (2012)

Post-radiation increase in VEGF enhances glioma cell motility in vitro
por: Kil, Whoon Jong, et al.
Publicado: (2012)

Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic
por: Shabason, Jacob E, et al.
Publicado: (2011)

DDRE-16. CYSTEINE IS AN ESSENTIAL AMINO ACID IN GLIOMAS
por: Ruiz-Rodado, Victor, et al.
Publicado: (2021)

TRPM8 is required for survival and radioresistance of glioblastoma cells
por: Klumpp, Dominik, et al.
Publicado: (2017)

Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience
por: Ho, Jennifer, et al.
Publicado: (2013)

Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer
por: Deng, Xiang, et al.
Publicado: (2023)

Radioresistance in Glioblastoma and the Development of Radiosensitizers
por: Ali, Md Yousuf, et al.
Publicado: (2020)

Analytical Considerations of Large-Scale Aptamer-Based Datasets for Translational Applications
por: Jiang, Will, et al.
Publicado: (2022)

STAT3 Contributes to Radioresistance in Cancer
por: Wang, Xuehai, et al.
Publicado: (2020)

Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
por: Lehman, Stacey L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9d1s6unll9a1jthgr20ibflmqb